Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

1,001

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Multiple Sclerosis
Interventions
DRUG

Teriflunomide

Pharmaceutical form: film-coated tablet; Route of administration: oral

Trial Locations (169)

1200

Investigational Site Number 056001, Brussels

1820

Investigational Site Number 056005, Melsbroek

2650

Investigational Site Number 056003, Edegem

2930

Investigational Site Number 056006, Brasschaat

3000

Investigational Site Number 056007, Leuven

4000

Investigational Site Number 056008, Liège

Investigational Site Number 056009, Liège

5021

Investigational Site Number 578002, Bergen

7800

Investigational Site Number 578003, Namsos

8500

Investigational Site Number 056002, Kortrijk

10043

Investigational Site Number 380005, Orbassano (TO)

10306

Investigational Site Number 840091, Staten Island

11521

Investigational Site Number 300002, Athens

11525

Investigational Site Number 300001, Athens

12099

Investigational Site Number 276003, Berlin

12308

Investigational Site Number 840071, Schenectady

13008

Investigational Site Number 250021, Marseille

13202

Investigational Site Number 840045, Syracuse

13530

Investigational Site Number 246004, Hämeenlinna

13616

Investigational Site Number 250003, Aix-en-Provence

14000

Investigational Site Number 250008, Caen

14004

Investigational Site Number 724010, Córdoba

14203

Investigational Site Number 840064, New York

15006

Investigational Site Number 724004, A Coruña

15061

Investigational Site Number 840053, Monaca

15706

Investigational Site Number 724006, Santiago de Compostela

19107

Investigational Site Number 840056, Philadelphia

20014

Investigational Site Number 724008, Donostia / San Sebastian

20132

Investigational Site Number 380001, Milan

20133

Investigational Site Number 380004, Milan

20520

Investigational Site Number 246001, Turku

Investigational Site Number 246003, Turku

21000

Investigational Site Number 250001, Dijon

21013

Investigational Site Number 380002, Gallarate (VA)

22182

Investigational Site Number 840054, Vienna

23226

Investigational Site Number 840070, Henrico

23298

Investigational Site Number 840109, Richmond

24018

Investigational Site Number 840017, Roanoke

25200

Investigational Site Number 250023, Montbéliard

26953

Investigational Site Number 250039, Valence

27103

Investigational Site Number 840090, Winston-Salem

28204

Investigational Site Number 840078, Charlotte

28401

Investigational Site Number 840074, Wilmington

28806

Investigational Site Number 840084, Asheville

29000

Investigational Site Number 250031, Quimper

30029

Investigational Site Number 250028, Nîmes

30120

Investigational Site Number 724001, El Palmar (murcia)

30318

Investigational Site Number 840002, Atlanta

31200

Investigational Site Number 250037, Toulouse

31210

Investigational Site Number 840075, Macon

33000

Investigational Site Number 250007, Bordeaux

33013

Investigational Site Number 840104, Hialeah

33014

Investigational Site Number 840101, Miami Lakes

33073

Investigational Site Number 840055, Coconut Creek

33351

Investigational Site Number 840081, Sunrise

33756

Investigational Site Number 840089, Clearwater

34239

Investigational Site Number 840059, Sarasota

34295

Investigational Site Number 250024, Montpellier

35209

Investigational Site Number 840077, Birmingham

37044

Investigational Site Number 250038, Tours

37215

Investigational Site Number 840048, Nashville

37388

Investigational Site Number 840035, Tullahoma

38043

Investigational Site Number 250015, Grenoble

40207

Investigational Site Number 840034, Louisville

41110

Investigational Site Number 300005, Larissa

43480

Investigational Site Number 752003, Kungsbacka

44093

Investigational Site Number 250027, Nantes

44718

Investigational Site Number 840003, Canton

46005

Investigational Site Number 250009, Cahors

46009

Investigational Site Number 724007, Valencia

47011

Investigational Site Number 724005, Valladolid

47923

Investigational Site Number 250002, Agen

48035

Investigational Site Number 840073, Clinton Township

51100

Investigational Site Number 250032, Reims

51429

Investigational Site Number 276001, Bergisch Gladbach

53215

Investigational Site Number 840038, Milwaukee

54956

Investigational Site Number 840076, Neenah

55422

Investigational Site Number 840068, Golden Valley

Investigational Site Number 840098, Golden Valley

59037

Investigational Site Number 250018, Lille

59185

Investigational Site Number 752002, Motala

59322

Investigational Site Number 250040, Valenciennes

60126

Investigational Site Number 380008, Ancona

63017

Investigational Site Number 840086, Chesterfield

63110

Investigational Site Number 840058, St Louis

64000

Investigational Site Number 250043, Pau

64109

Investigational Site Number 250006, Bayonne

65185

Investigational Site Number 752001, Karlstad

67091

Investigational Site Number 250035, Strasbourg

68024

Investigational Site Number 250012, Colmar

68100

Investigational Site Number 250025, Mulhouse

68521

Investigational Site Number 840026, Lincoln

69275

Investigational Site Number 250020, Lyon

70124

Investigational Site Number 380009, Bari

72037

Investigational Site Number 250017, Le Mans

73000

Investigational Site Number 250011, Chambéry

74370

Investigational Site Number 250022, Metz-Tessy

75013

Investigational Site Number 250016, Paris

75246

Investigational Site Number 840060, Dallas

75970

Investigational Site Number 250029, Paris

76000

Investigational Site Number 250033, Rouen

76063

Investigational Site Number 840052, Mansfield

78100

Investigational Site Number 250030, Saint-Germain-en-Laye

78229

Investigational Site Number 840028, San Antonio

79098

Investigational Site Number 276004, Freiburg im Breisgau

80054

Investigational Site Number 250005, Amiens

80113

Investigational Site Number 840016, Englewood

80138

Investigational Site Number 380006, Napoli

80304

Investigational Site Number 840097, Boulder

80528

Investigational Site Number 840094, Fort Collins

80907

Investigational Site Number 840040, Colorado Springs

81000

Investigational Site Number 250004, Albi

85004

Investigational Site Number 840087, Phoenix

85008

Investigational Site Number 840114, Phoenix

85258

Investigational Site Number 840080, Scottsdale

85704

Investigational Site Number 840032, Tucson

87000

Investigational Site Number 250019, Limoges

89012

Investigational Site Number 840020, Henderson

90220

Investigational Site Number 246006, Oulu

90806

Investigational Site Number 840108, Long Beach

92056

Investigational Site Number 840019, Oceanside

92663

Investigational Site Number 840014, Newport Beach

92835

Investigational Site Number 840018, Fullerton

Investigational Site Number 840037, Fullerton

Unknown

Investigational Site Number 840007, Cullman

Investigational Site Number 840021, Phoenix

Investigational Site Number 840011, Ormond Beach

Investigational Site Number 840008, St. Petersburg

Investigational Site Number 840012, Fort Wayne

Investigational Site Number 840010, Indianapolis

Investigational Site Number 840005, New York

Investigational Site Number 840042, Raliegh

Investigational Site Number 840105, Sanford

Investigational Site Number 840041, Bismarck

Investigational Site Number 840009, Dayton

Investigational Site Number 840112, Milwaukee

Investigational Site Number 040-001, Linz

Investigational Site Number 040-002, Vienna

Investigational Site Number 152003, Concepción

Investigational Site Number 152001, Santiago

Investigational Site Number 152005, Santiago

Investigational Site Number 246005, Kuopio

Investigational Site Number 250026, Nancy

CO

Investigational Site Number 840046, Denver

FL

Investigational Site Number 840024, Bradenton

04843

Investigational Site Number 840047, Rockport

02035

Investigational Site Number 840107, Foxborough

01104

Investigational Site Number 840030, Springfield

07728

Investigational Site Number 840049, Freehold

08755

Investigational Site Number 840044, Toms River

11733-345

Investigational Site Number 840100, East Setauket

02920

Investigational Site Number 840072, Cranston

99220-3649

Investigational Site Number 840069, Spokane

26506-9180

Investigational Site Number 840079, Morgantown

N1R7L6

Investigational Site Number 124006, Cambridge

E2L 4L2

Investigational Site Number 124007, St. John's

03201

Investigational Site Number 250013, Vichy

546 36

Investigational Site Number 300004, Thessaloniki

0407

Investigational Site Number 578001, Oslo

08035

Investigational Site Number 724002, Barcelona

B152TH

Investigational Site Number 826-005, Birmingham

BN25BE

Investigational Site Number 826-003, Brighton

G116NT

Investigational Site Number 826-007, Glasgow

LS13EX

Investigational Site Number 826-008, Leeds

LE54PW

Investigational Site Number 826-010, Leicester

SW170QT

Investigational Site Number 826-009, London

nr34dg

Investigational Site Number 826-001, Norwich

RM70AG

Investigational Site Number 826-006, Romford

M68HD

Investigational Site Number 826-004, Salford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT01895335 - Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients | Biotech Hunter | Biotech Hunter